Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro.

Slides:

Advertisements

Similar presentations

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Advertisements

Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection Na Huang, M.S., Bing Situ, M.S., Xiao.

Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during.

Does Previous Salpingectomy Improve Implantation and Pregnancy Rates in Patients with Severe Tubal Factor Infertility who are Undergoing In Vitro Fertilization?

Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women3 Howard Levine,

Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation Renato.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States Jennifer.

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients N. Ellissa Baskind, M.B.Ch.B.,

Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program Fady I Sharara, M.D.,

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age Sanja Kupesic, M.D., Ph.D., Asim Kurjak,

In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors Ahmad O. Hammoud, M.D.,

Laura D. Almquist, M. D. , Creighton E. Likes, M. D

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Simone L. Broer, B.Sc., Ben Willem J.

Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer Renato Fanchin, M.D., Claudia Righini, M.D., Dominique.

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes Jin-Ho Lim, M.D., Seong-Ho Yang,

Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization5

Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization–embryo transfer Bruno Tarasconi, M.D.,

Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study Ahmet Erdem, M.D., Mehmet Erdem,

Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates Amy.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

Mark D Hornstein, M. D. , Owen K Davis, M. D. , Joe B Massey, M. D

Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged.

A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome Uma Deve Gordon, M.D., Robert F Harrison,

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Introduction Fertility and Sterility

Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Massimo Tartagni, M. D. , Luca Maria Schonauer, M. D

Comparison of two methods for the measurement of sperm concentration

A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization Nathalie Lédée-Bataille,

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.

Dizygotic twin delivery following in vitro fertilization and transfer of thawed blastocysts cryopreserved at day 6 and 7 E.Scott Sills, M.D., Cindy L.

Why do couples discontinue in vitro fertilization treatment

Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans Jean-Marc.

Regulation of assisted reproductive technologies in the United States

Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization–embryo transfer cycle outcome Eric S Surrey,

Effect of endometriosis on in vitro fertilization

Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss Mary D. Stephenson, M.D., M.Sc., Dana.

Temporal and morphologic characteristics of pinopod expression across the secretory phase of the endometrial cycle in normally cycling women with proven.

Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa.

Annette Gruschke, M.D., Herbert Kuhl, Ph.D. Fertility and Sterility

Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer Jennifer L Phy, D.O., William T Weiss, R.Ph., Catherine R Weiler,

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization–embryo transfer Mohamed.

In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (ICSI) Using Sperm Exposed to Cyclophosphamide Reduces Preimplantation Embryo Development.

Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study Laurel Stadtmauer, M.D.,

Withholding gonadotropins (“coasting”) to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization–embryo transfer.

Interleukin-1β and interleukin-1α may affect the implantation rate of patients undergoing in vitro fertilization–embryo transfer Evdokia E Karagouni,

Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines Dolors Manau,

M. Rafet Gazvani, Michelle Bates, Gillian Vince, Ph. D

Peter F Donderwinkel, M. D

Luteal phase support Fertility and Sterility

Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human.

Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D.

Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success G.Wright Bates, M.D., Elizabeth S Ginsburg, M.D.

Cervical pregnancy Fertility and Sterility

Briana J. Rudick, M. D. , Sue Ann Ingles, Ph. D. , Karine Chung, M. D

Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels Antonio Requena, M.D., María Cruz, Ph.D.,

Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone⁎ 8% gel and Utrogestan† capsules, used for luteal.

The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production Antonio Pellicer, M.D., Carmela Albert,

Emotional adaptation following successful in vitro fertilization

The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women Beth A. Malizia, M.D., Laura.

Presentation transcript:

Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro fertilization Marc Germond, M.D., Paola Capelli, M.D., Giuliana Bruno, M.D., Sara Vesnaver, M.D., Alfred Senn, Ph.D., Nathalie Rouge, Pharm.D., Ph.D., J Biollaz, M.D. Fertility and Sterility Volume 77, Issue 2, Pages 313-317 (February 2002) DOI: 10.1016/S0015-0282(01)02979-X

FIGURE 1 Progesterone plasma concentration after Ellios™ (n = 60, ▴) and Utrogestan™ (n = 63, •) administration. Broken and solid lines refer to nonpregnant and pregnant patients, respectively. Germond. Vaginal progesterone support and IVF. Fertil Steril 2002. Fertility and Sterility 2002 77, 313-317DOI: (10.1016/S0015-0282(01)02979-X)